CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-26 | Giacobello Scott M. Chief Financial Officer | Grant or award | +20,000 | $12.50 | $250K | 20,000 |
| 2022-09-22 | Aghazadeh Behzad Director | Grant or award | +1,260,000 | $12.50 | $15.8M | 3,471,752 |
| 2022-06-15 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-06-15 | Maroun Richard E Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-06-15 | Hehenberger Karin M. Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-06-15 | Dalal Anupam Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-06-15 | Castelein Caley Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-06-15 | Aghazadeh Behzad Director | Grant or award · Stock Option (right to buy) | +18,573 | 18,573 | ||
| 2022-04-01 | Delaney Brendan Chief Operating Officer | Grant or award · Stock option (right to buy) | +61,000 | 61,000 | ||
| 2022-04-01 | ITRI LORETTTA M Chief Medical Officer | Grant or award · Stock option (right to buy) | +67,300 | 67,300 | ||
| 2022-04-01 | Giacobello Scott M. Chief Financial Officer | Grant or award · Stock option (right to buy) | +46,400 | 46,400 | ||
| 2022-04-01 | Desai Neil See Remarks | Grant or award · Stock option (right to buy) | +153,300 | 153,300 | ||
| 2022-03-18 | Desai Neil See Remarks | Sale | −3,550 | $20.07 | $71K | 1,915,543 |
| 2021-10-21 | ITRI LORETTTA M Chief Medical Officer | Grant or award · Stock option (right to buy) | +185,000 | 185,000 | ||
| 2021-09-20 | Delaney Brendan Chief Operating Officer | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | ||
| 2021-09-08 | Desai Neil See Remarks | Grant or award · Stock option (right to buy) | +125,000 | 125,000 | ||
| 2021-09-08 | Reeve Emma Director | Grant or award · Stock option (right to buy) | +16,486 | 16,486 | ||
| 2021-08-27 | Hehenberger Karin M. Director | Grant or award · Stock option (right to buy) | +17,549 | 17,549 | ||
| 2021-08-27 | Maroun Richard E Director | Grant or award · Stock option (right to buy) | +17,549 | 17,549 | ||
| 2021-08-27 | Aghazadeh Behzad Director | Grant or award · Stock option (right to buy) | +17,549 | 17,549 |
Page 10 of 16 · 312 trades